EUVIMEDEUVIMED entdecken
Crossref

HM-Chromanone Alleviates Hyperglycemia by Protecting Pancreatic Islet Cells in Streptozotocin-Induced Diabetic Mice

Jae Eun Park, Ji Sook Han iD

Journal of Medicinal Food · 2023

DOI: 10.1089/jmf.2022.k.0084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Food, 2023. Verfasst von Jae Eun Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition & Kimchi Research Institute, Pusan National University, Busan, Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Islets of Langerhans, Hyperglycemia, Insulin-Secreting Cells. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We examined the effects of HM-chromanone (HMC) on alleviating hyperglycemia and protecting pancreatic β-cells from streptozotocin (STZ)-induced damage in C57BL/6J mice. HMC was administered to STZ-induced diabetic mice at 10 or 30 mg/kg, for 14 days. Thereafter, changes in fasting blood glucose levels, insulin-secretion, histopathological examination of pancreas islet cell and apoptotic protein levels, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay were determined. The results revealed that HMC dose-dependently improved blood glucose concentrations and alleviated pancreatic islet cells damage. In diabetic mice, degeneration of the islet cells was observed wherein they appeared shrunken, with hyaline deterioration, nuclear dissolution, and condensation. However, morphology of the islet cell was restored, and nuclei were visibly rounded in the HMC (30 mg/kg)-administered diabetic mice. In addition, β-cell numbers were markedly increased in HMC mice compared to STZ-induced diabetic mice, and the number of cells stained with glucagon was decreased. HMC markedly decreased the expression of proapoptotic proteins and increased antiapoptotic proteins, and the number of apoptotic cells detected by TUNEL was elevated. HMC decreased expression of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in diabetic mice. Moreover, HMC increased antioxidant-enzymes activity, and decreased reactive oxygen species generation. In conclusion, the results demonstrate the potential of HMC to alleviate hyperglycemia by protecting the pancreatic β-cells in diabetic mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalIslets of LangerhansHyperglycemiaInsulin-Secreting CellsMiceAnimalsStreptozocinInsulinBlood GlucoseMice, Inbred C57BLAntioxidantsIsoflavones

Stichwörter der Autor:innen

C57BL/6J miceHM-chromanonehyperglycemiapancreatic β-cellsstreptozotocin

Substanzen

StreptozocinInsulinBlood GlucoseAntioxidantsHM-chromanoneIsoflavones

Autor:innen und Institutionen

  • Department of Food Science and Nutrition & Kimchi Research Institute, Pusan National University, Busan, Korea.

ORCID-Profile: Ji Sook Han

Zitieren

APA

Park, J. E., & Han, J. S. (2023). HM-Chromanone Alleviates Hyperglycemia by Protecting Pancreatic Islet Cells in Streptozotocin-Induced Diabetic Mice. Journal of Medicinal Food. https://doi.org/10.1089/jmf.2022.k.0084

Vancouver

Park JE, Han JS. HM-Chromanone Alleviates Hyperglycemia by Protecting Pancreatic Islet Cells in Streptozotocin-Induced Diabetic Mice. Journal of Medicinal Food. 2023. doi:10.1089/jmf.2022.k.0084

BibTeX
@article{Park2023,
  author = {Park, Jae Eun and Han, Ji Sook},
  title = {HM-Chromanone Alleviates Hyperglycemia by Protecting Pancreatic Islet Cells in Streptozotocin-Induced Diabetic Mice},
  journal = {Journal of Medicinal Food},
  year = {2023},
  doi = {10.1089/jmf.2022.k.0084}
}
Kostenlos starten →